as on December 8, 2025 at 4:01 pm IST
Day's Low
Day's High
1.50%
Downside
1.85%
Upside
52 Week's Low
52 Week's High
3.76%
Downside
67.00%
Upside
as on December 8, 2025 at 4:01 pm IST
Market Cap
₹268.62 Cr
Return on Equity (ROE)
6.69
PE Ratio (TTM)
6.22
Return on capital employed (ROCE)
7.25
Industry PE ratio
58.33
Beta (LTM)
1.08
P/B Ratio
0.43
Dividend Yield
1.37
PEG Ratio
7.58
Quarterly Earnings Growth YOY
147.75
EPS (TTM)
20.31
Sector
FMCG
Book Value
339.08
Technical Analysis
Bearish
View Technical Analysis
as on December 8, 2025 at 4:01 pm IST
Nath Bio-Genes (India) Ltd in the last 5 years
Lowest (-3.78x)
January 3, 2023
Today (6.22x)
December 5, 2025
Industry (58.33x)
December 5, 2025
Highest (11.85x)
August 4, 2023
Today’s Price to Earnings Ratio: 6.22x
Compare market cap, revenue, PE, and other key metrics of Nath Bio-Genes (India) Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 268.62 | -10.01% | 0.58 | 38 | 364 | |
| NA | 93.99 | 31.72% | 0.00 | 1 | 426 | |
| NA | 54.58 | 47.68% | 0.00 | 3 | 490 | |
| NA | 80.79 | 15.42% | 0.00 | 4 | 147 | |
| NA | 89.46 | -9.63% | 0.52 | -20 | 92 |
Search interest for Nath Bio-Genes (India) Ltd Stock has increased by 39% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:39% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Nath Bio-Genes (India) Ltd.
Nath Bio-Genes (India) Ltd’s net profit jumped 147.75% since last year same period to ₹2.75Cr in the Q2 2025-2026. On a quarterly growth basis, Nath Bio-Genes (India) Ltd has generated -92.62% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Nath Bio-Genes (India) Ltd has declared dividend of ₹2.00 per share on 29 Apr 2025 - translating a dividend yield of 2.83%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
![]()
Retail Investor have increased holdings from 51.74% to 53.32% in Sep 2025 quarter
Promoter Holding Unchanged
![]()
Promoters holdings remained unchanged at 45.60% of holdings in Sep 2025 quarter
Against Peers
![]()
In the last 1 year, Avanti Feeds Ltd has given 30.3% return, outperforming this stock by 60.6%
Against Peers
![]()
In the last 3 years, Avanti Feeds Ltd has given 103.6% return, outperforming this stock by 124.6%
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 0.41% to 0.32% in Sep 2025 quarter
Profit Down
![]()
Netprofit is down for the last 2 quarters, 37.28 Cr → 2.75 Cr (in ₹), with an average decrease of 92.6% per quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 287.53 Cr → 47.85 Cr (in ₹), with an average decrease of 83.4% per quarter
Price Dip
![]()
In the last 7 days, NATHBIOGEN stock has moved down by -10.4%
MF Holding Down
![]()
Mutual Funds have decreased holdings from 2.25% to 0.76% in Sep 2025 quarter
| Organisation | Nath Bio-Genes (India) Ltd |
| Industry | FMCG |
| E-voting on shares | Click here to vote |
Nath Bio-Genes (India) Ltd share price today stands at ₹142.93 as on at the close of the market. Nath Bio-Genes (India) Ltd share today touched a day high of ₹145.58 and a low of ₹140.79.
Nath Bio-Genes (India) Ltd touched a 52 week high of ₹238.69 and a 52 week low of ₹137.55. Nath Bio-Genes (India) Ltd share price today i.e. is closed at ₹142.93, which is -40.12% down from its 52 week high and 3.91% up from its 52 week low.
Nath Bio-Genes (India) Ltd market capitalisation is ₹268.62 Cr as on .
To buy Nath Bio-Genes (India) Ltd shares, you need to follow these steps:
Nath Bio-Genes (India) Ltd trading volume is 21.46K as on . This means that 21.46K shares of Nath Bio-Genes (India) Ltd were bought and sold on the stock market during today's trading session.